PMID- 7861762 OWN - NLM STAT- MEDLINE DCOM- 19950323 LR - 20171116 IS - 0022-4804 (Print) IS - 0022-4804 (Linking) VI - 58 IP - 2 DP - 1995 Feb TI - Tumor necrosis factor-alpha and interleukin-6 selectively regulate neutrophil function in vitro. PG - 124-30 AB - The neutrophil is an important effector cell of the host response to sepsis. Tumor necrosis factor-alpha (TNF-alpha), a cytokine mediator of the septic response, is rapidly released following endotoxemia or gram-negative bacteremia. Interleukin-6 (IL-6) is another cytokine mediator of the host response to sepsis whose role is less well understood than that of TNF-alpha. It is known to be elevated in gram-negative sepsis, where peak levels have been correlated with mortality. This study examined the effect of IL-6 alone and in combination with TNF-alpha on three neutrophil functions--CD18 adhesion receptor expression, phagocytosis, and superoxide anion generation. Neutrophils from human volunteers were incubated with amounts of IL-6 ranging from 10 to 1000 ng/ml. At a concentration of 1000 ng/ml, IL-6 increased neutrophil phagocytosis of opsonized bacteria (826 +/- 255 x 10(3) MESF vs 552 +/- 103 MESF, P < 0.05) and also increased neutrophil superoxide anion generation (18.41 +/- 1.86 vs 12.6 nmol O2-/10(6) PMN/10 min, P < 0.05). Lesser amounts of IL-6 had no effect on phagocytosis or superoxide generation. IL-6 did not increase neutrophil CD18 adhesion receptor expression. Combining IL-6 with TNF-alpha at doses of 100 ng/ml and 100 U/ml, respectively, neutrophil phagocytosis (221 +/- 455 MESF vs 552 +/- 103 MESF) and superoxide generation (23.18 +/- 1.86 vs 12.6 nmol O2-/10(6) PMN/10 min) were significantly (P < 0.05) increased above control by an amount similar to that seen with 1000 U/ml TNF-alpha alone.(ABSTRACT TRUNCATED AT 250 WORDS) FAU - Mullen, P G AU - Mullen PG AD - Department of Surgery, Medical College of Virginia--Virginia Commonwealth University, Richmond 23298. FAU - Windsor, A C AU - Windsor AC FAU - Walsh, C J AU - Walsh CJ FAU - Fowler, A A 3rd AU - Fowler AA 3rd FAU - Sugerman, H J AU - Sugerman HJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PL - United States TA - J Surg Res JT - The Journal of surgical research JID - 0376340 RN - 0 (CD18 Antigens) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) RN - 11062-77-4 (Superoxides) SB - IM MH - Adult MH - CD18 Antigens/analysis MH - Humans MH - Interleukin-6/*pharmacology MH - Male MH - Neutrophils/*drug effects/physiology MH - Phagocytosis/drug effects MH - Superoxides/metabolism MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 1995/02/01 00:00 MHDA- 2001/03/28 10:01 CRDT- 1995/02/01 00:00 PHST- 1995/02/01 00:00 [pubmed] PHST- 2001/03/28 10:01 [medline] PHST- 1995/02/01 00:00 [entrez] AID - S0022-4804(85)71020-7 [pii] AID - 10.1006/jsre.1995.1020 [doi] PST - ppublish SO - J Surg Res. 1995 Feb;58(2):124-30. doi: 10.1006/jsre.1995.1020.